The GEMSilk Project – Pioneering Medical-Silk Biopolymers

© Fraunhofer IME
PhD candidate Franziska Lai performing microinjection on silkworm eggs.
© Fraunhofer IME
Srinithi Kirubakaran (MSc. student) preparing silkworms for analysis.

The next generation of medical adhesives: silk that heals

Gluing things together inside the human body is not easy. Anyone who has tried to stick a plaster on wet skin knows how frustrating it can be. In surgery, doctors often need to reconnect tissues or seal internal wounds in moist environments, but existing medical glues struggle to hold. Stitches and staples are still the standard, but wouldn’t a glue be quicker, gentler, and more adaptable?

Unfortunately, many current surgical adhesives are far from ideal. Some are strong but toxic to tissues and don't bond well to wet surfaces. Others are safer but weak and unreliable. The consequences can be serious. For instance, after abdominal surgery, internal leaks at the surgical site affect up to one in five patients. Clearly, better medical adhesives are urgently needed.

Nature may already hold the answer. Some animals produce waterproof silk that works like underwater tape. These natural glues are strong, fast-setting, and highly effective on wet surfaces, exactly what surgeons are looking for. The challenge is that these insects are small and cannot be farmed to harvest their sticky silk in useful quantities. What if we could equip silk-producing insects to do the job?

This is the goal of GEMSilk, Genetically Engineered Medical Silk. Funded by Horizon Europe through a Marie Skłodowska-Curie Postdoctoral Fellowship, one of the EU’s flagship funding schemes for researchers, GEMSilk takes an innovative approach: genetically modifying the domestic silkworm to produce a new kind of silk that acts as a biocompatible glue for medical use. The project builds on the researcher’s earlier doctoral experience, funded through a Marie Skłodowska-Curie doctoral training programme, which focused on the genetic engineering of silkworms to promote sustainable commercial sericulture. Guided by Prof. Philipp Seib, whose research bridges biopolymers and healthcare innovation, the project brings together genetic engineering and materials science to develop next-generation silk adhesives. The project is also supported by PhD candidate Franziska Lai and MSc. student Srinithi Kirubakaran.

Applying the principles of biomimetics, the science of learning from nature to solve human challenges, the team aims to create a sustainable and scalable source of medical adhesive. This work blends biology, biotechnology and materials science to address a long-standing clinical need.

Silk: An Ancient Material Reinvented

Silkworms have been cultivated for thousands of years. Their silk, a single thread that can stretch over a kilometre, is strong, light and smooth. For centuries, silk has been used in sutures and more recently in modern wound dressings and surgical meshes. It is safe to use in the human body, gradually biodegrades and does not trigger strong immune responses.

Silkworms are ideal production hosts. They are domesticated, easy to rear and capable of producing large amounts of silk. This makes them a reliable biofactory. Scientists have already engineered silkworms to produce hybrid fibres, including variants that mimic spider silk, which is valued for its strength and elasticity.

But natural silkworm silk, while strong, is not sticky to touch. It is made to build protective cocoons, not to adhere to surfaces. Silk actually repels water, which makes it difficult to use as a tissue adhesive. That is why GEMSilk is not just harvesting silk, it is rewriting the genetic instructions silkworms use to produce it. By introducing adhesive properties into the silk’s genetic structure, the silkworms express an entirely new material. This new silk keeps the benefits of traditional silk and gains the ability to bond tissues together in wet environments.

© Fraunhofer IME
Silkworm larva with a visible silk thread (red arrow) produced from the spinneret.
Female (left) and male (right) silk cocoons and pupae.
© Fraunhofer IME
Female (left) and male (right) silk cocoons and pupae.

Inside the Cocoon: Giving Silkworms a New Skill

Creating silk that sticks requires a rewrite of the silkworm’s genetic code. The GEMSilk team uses a technology called CRISPR/Cas9. This method allows scientists to make precise edits to DNA. Think of it as molecular surgery: cutting the DNA at exactly the right point and inserting a new set of instructions.

Dr. Brady designed a stretch of DNA carrying the genetic blueprint for adhesive protein segments. With the help of CRISPR/Cas gene editing technology, this DNA will be incorporated into the silkworm’s genome. The result is a hybrid gene that still tells the silkworm to produce silk, but now includes added glue-like properties.

This edit is made at the earliest stage of the silkworm’s development. Female moths lay tiny eggs, each smaller than a matchstick head. These eggs are injected under a microscope using a fine glass needle. The injection delivers the CRISPR components and the donor DNA into the embryo just hours after the egg is laid. This stage is delicate and precise.

To identify which silkworms, carry the modified gene, a small fluorescent marker is also included. Under the microscope, hatchlings with the new gene will have a red glow in their eyes. These individuals are bred and screened to establish a new, stable strain of silkworms that consistently produce the adhesive silk. Once established, this strain becomes a living production line for the new biomaterial. Unlike many other model insects, including Drosophila, silkworm eggs can be stored as eggs for up to a year, meaning perpetual rearing is not required.

© Fraunhofer IME | Jennifer Kuhn
Adult silkmoth.

Growing a New Kind of Silk

When the genetically modified silkworm line is established, the next step is testing the silk they produce. The silkworms are reared in controlled conditions at Fraunhofer IME Gießen’s insect biotechnology facility. After the larvae spin their cocoons, the silk will be harvested and analysed.

The most important question is simple: does it stick? Using mechanical testing, microscopy and tissue models, Dr. Brady will assess the glue-like performance of the new silk, and how well it bonds to moist tissue surfaces, how much force it can withstand and how it behaves under strain.

Equally important is safety. Medical adhesives must be biocompatible. They must not cause inflammation, allergic reactions or toxicity. Natural silk already has an excellent safety record, and the modifications introduced in GEMSilk are designed to maintain this profile. The new silk glue is protein-based and biodegradable, meaning it could dissolve harmlessly in the body as healing progresses.

This silk glue could be processed into patches, tapes or gels depending on the intended medical use. For example, a strip of adhesive silk might be pressed over a surgical incision, sealing it in place without stitches. In future versions, the glue could even be sprayed into the body through a scope or syringe for hard-to-reach areas.

A Platform for Biomedicine and Beyond

GEMSilk’s goals go beyond producing one type of medical glue. The project is building a platform for bio-inspired materials. By equipping silkworms with different genetic instructions, they could be used to spin a range of materials. These could include surgical adhesives, high-performance fibres or bioactive coatings.

Silkworms also offer a scalable production method. A small breeding facility can generate thousands of cocoons, each containing a kilometre of silk fibre. The infrastructure for silkworm rearing already exists in many parts of the world. The genetic modifications used in GEMSilk are designed to fit within that system. The silk glue could be produced in commercial quantities using traditional farming methods.

The research is also contributing to Fraunhofer IME’s broader mission to promote insects in biotechnology. GEMSilk has led to the development of new microinjection facilities, gene editing protocols and improved know-how. These advances are strengthening the institute’s capacity to develop bio-based materials and expanding its potential in applied research.

© Fraunhofer IME
Mature larvae preparing to spin their silk cocoons.

The Road Ahead

Silk glue is not yet in operating theatres, but by the end of the project, Dr. Brady aims to have a functional strain of glue-producing silkworms and a silk material with verified adhesive properties. Further testing and development will be needed to meet regulatory standards for medical use.

© Fraunhofer IME
Newly hatched silkworm.

Looking ahead, the potential benefits are clear. A reliable, biocompatible adhesive that works on wet tissues could improve outcomes for patients and reduce complications after surgery. Surgeons might one day have a new tool that closes wounds faster and more safely. For patients, this could mean fewer stitches, less scarring and quicker recovery.

GEMSilk also shows what can happen when scientists take inspiration from nature, borrowing one insect’s solution and placing it into another, to create something entirely new. The silk of the future may not just be for textiles. It may one day help seal wounds, repair organs and speed healing. In doing so, it could help healthcare stick together in more ways than one.

Are you also interested in this topic? Then please contact us!

If you are interested in a collaboration or a research and development service, please contact us!

 

We will jointly assess your problem and evaluate whether we can address it with our platform and our analysis methods.

 

Dr. Daniel Brady

PostDoc

Fraunhofer Institute for Molecular Biology and Applied Ecology IME
Ohlebergsweg 12
35392 Gießen, Deutschland

Phone 064197219-305

 

Biodiversity research